Fidelity Investments’s Span-America Medical Systems I SPAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-354,103
Closed -$7.58M 2767
2017
Q1
$7.58M Buy
354,103
+500
+0.1% +$10.3K ﹤0.01% 2060
2016
Q4
$6.45M Buy
353,603
+11,552
+3% +$213K ﹤0.01% 2112
2016
Q3
$6.4M Buy
342,051
+753
+0.2% +$13.6K ﹤0.01% 2133
2016
Q2
$6.11M Buy
341,298
+16,143
+5% +$292K ﹤0.01% 2132
2016
Q1
$6.18M Buy
325,155
+16,092
+5% +$306K ﹤0.01% 2100
2015
Q4
$6.13M Buy
309,063
+2,100
+0.7% +$39.4K ﹤0.01% 2132
2015
Q3
$5.42M Buy
306,963
+7,714
+3% +$138K ﹤0.01% 2153
2015
Q2
$5.51M Buy
299,249
+10,249
+4% +$195K ﹤0.01% 2208
2015
Q1
$5.59M Hold
289,000
﹤0.01% 2189
2014
Q4
$4.91M Hold
289,000
﹤0.01% 2235
2014
Q3
$5.43M Hold
289,000
﹤0.01% 2201
2014
Q2
$6.13M Hold
289,000
﹤0.01% 2190
2014
Q1
$6.68M Hold
289,000
﹤0.01% 2136
2013
Q4
$6.02M Buy
289,000
+1,000
+0.3% +$19.4K ﹤0.01% 2119
2013
Q3
$6.2M Hold
288,000
﹤0.01% 2097
2013
Q2
$5.65M Buy
+288,000
New +$5.62M ﹤0.01% 2102

Other funds holding SPAN

Fidelity Investments's SPAN Position: Q2 2017 in Review

Fidelity Investments sold out of Span-America Medical Systems I (SPAN) in Q2 2017, closing a stake of 354,103 shares — an estimated $7.58M sold.

Fidelity Investments first reported a position in SPAN in Q2 2013 and held it in 16 quarters. The position peaked at $7.58M in Q1 2017. 2 funds tracked by Wall St. Rank hold SPAN as of Q2 2017.

  • Fidelity Investments reported no remaining Span-America Medical Systems I position as of Q2 2017 after selling out during the quarter.
  • Fidelity Investments sold 354,103 Span-America Medical Systems I shares in Q2 2017, an estimated $7.58M.
  • Fidelity Investments first reported a position in Span-America Medical Systems I in Q2 2013 and held it in 16 quarters.
  • Fidelity Investments's Span-America Medical Systems I position peaked at $7.58M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Span-America Medical Systems I as of Q2 2017.

Based on Fidelity Investments's 13F filing for Q2 2017, filed 11 Aug 2017.